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Introduction
Systemic autoinflammatory diseases (SAIDs) are a group of
monogenic disorders characterized by inflammation which
occurs in the absence of pathogenic auto-antibodies, auto-
reactive T lymphocytes or other infective causes. More
than 50% of SAID patients recruited to our Unit does not
show any mutation at gene(s) tested by direct Sanger
sequencing in the routine diagnosis. Clinical misdiagnosis,
mutations in untested gene regions and genetic heteroge-
neity are possible explanations.
Objectives
To improve both the molecular diagnosis and genotype
interpretation of SAIDs, we aimed at the development of
a Next Generation Sequencing based protocol, designed
for the simultaneous screening of ten genes known to be
involved in a remarkable proportion of SAIDs. Different
bio-informatics approaches were taken into consideration
in order to define the best pipeline for variants detection.
Patients and methods
A panel of gene amplicons specific for the diseases under
study was designed through the Ion AmpliSeq™ designer
software. Fifty SAID patients, already genotyped for the
respective causative gene(s), were massively sequenced
for the coding portions of MEFV, MVK, TNFRSF1A,
NLRP3, NLRP12, NOD2, PSTPIP1, IL1RN, LPIN2 and
PSMB8. Three different bio-informatics pipelines, Ion
Reporter™, CLC Bio Genomics Workbench, and GATK-
based in-house workflow, were compared
Results
The approach we propose here for NGS-based diagnosis
of SAIDs, has resulted technically suitable, with a very
high mean coverage (336X) and nearly full detection of
variants. Besides expected mutation, we could also identify
many unexpected variants that were all validated by
Sanger sequencing and compared to assess true and false
positive detection rates of the three workflows. Finally, the
overall clinical picture of 34 patients were re-evaluated in
the light of the new mutations found.
Conclusions
The present gene panel has resulted suitable for molecu-
lar diagnosis of SAIDs. Besides causative mutations,
most patients have turned out to carry variants of
unclear significance that will need further investigation.
Moreover, genotype-phenotype correlation drawn in
34 patients has confirmed a remarkably difficult inter-
pretation of NGS data in patients with an undefined or
complex inflammatory phenotype. This supports the
need of evidence-based and validated clinical criteria as
crucial tools to be used concurrently with the genetic
analysis for the final diagnosis and classification of
SAIDs patients. In addition to setting a first approach to
mutational detection in SAIDs, patients left without a1IRCCS G Gaslini, UOC Medical Genetics, Genoa, Italy
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clear diagnosis will be identified as candidate for the
successive NGS analysis of the whole exome.
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